Search results
Results from the WOW.Com Content Network
In 2005, the Bush Administration enacted the Patient Navigation and Chronic Disease Prevention Act, the first American legislation to recognize patient navigators. [3] The Act allowed federal funding of 20 patient navigator programs that served patients with various chronic medical conditions. [3]
A clinical pathway is a multidisciplinary management tool based on evidence-based practice for a specific group of patients with a predictable clinical course, in which the different tasks (interventions) by the professionals involved in the patient care are defined, optimized and sequenced either by hour (ED), day (acute care) or visit (homecare).
Patient advocates give a voice to patients, survivors and their carers on healthcare-related (public) fora, informing the public, the political and regulatory world, health care providers (hospitals, insurers, pharmaceutical companies etc.), organizations of health care professionals, the educational world, and the medical and pharmaceutical ...
Patient history and needs are identified. Both the patient and the care navigator think through short- and long-term goals and levels of treatment sought. [9] Dialogue & Plan Formation. Through discussion and collaboration, both the patient and care navigator brainstorm next steps, establishing a plan that is specific to the patient's needs. [9]
It is a role frequently overseen by patient advocates. [1] It refers to the planning and coordination of health care services appropriate to achieve the goal of medical rehabilitation. Medical case management may include, but is not limited to, care assessment, including personal interview with the injured employee, and assistance in developing ...
The medical home, [1] also known as the patient-centered medical home or primary care medical home (PCMH), is a team-based health care delivery model led by a health care provider [2] to provide comprehensive and continuous medical care to patients with a goal to obtain maximal health outcomes.
Pronunciation follows convention outside the medical field, in which acronyms are generally pronounced as if they were a word (JAMA, SIDS), initialisms are generally pronounced as individual letters (DNA, SSRI), and abbreviations generally use the expansion (soln. = "solution", sup. = "superior").
Harold P. Freeman (born March 2, 1933) is an American physicist. He is an authority on race, poverty and cancer. [1] In his work in Harlem, Freeman identified the impact of poverty and cultural barriers on rates of cancer incidence and cancer-related death, in economically disadvantaged and under-served communities. [1]